SpringWorks Therapeutics, Inc. financial metrics

Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic. Latest period: Q1 2025.

Location
Stamford, CT
Fiscal year end
31 December
Latest financial report
09 May 2025

Quick Takeaways

  • SpringWorks Therapeutics, Inc. financial facts are built from SEC company filings data.
  • Latest metrics period on this page: Q1 2025.
  • Headline metric: Return On Equity -52%.

What Changed

  • Return On Equity YoY change: <span class="text-red-600">-18%</span>.
  • Most recent SEC facts end date: 02 May 2025.

Why This Matters

  • This gives a beginner-friendly first read before you inspect detailed formulas and metric tables.
  • Every metric card links to a deeper SEC-backed history page for verification.

Official SEC Source

Based on latest 10-Q/10-K

Facts and ratios are grounded in SEC company facts linked to the latest 10-Q/10-K cycle.

See Original Filing

Latest SEC snapshot (2025-05-02) highlights Return On Equity -51.6%, Return On Assets -43.7%, and Current Ratio 4.33x.

Financial Quality Score

Transparent 0-100 scoring model based on profitability, financial health, and growth factors.

42.9/100

Caution Confidence medium

Return On Equity

-52%

Metric score 0.0/100

Return On Assets

-44%

Metric score 0.0/100

Financial Health

Current Ratio
4.33x
Quick Ratio
5.14x
Debt to Equity
0.17x

Strengths

Debt-to-equity and NetIncomeLoss YoY

Watchpoints

Return On Equity, Return On Assets, and Quick Ratio

Key metrics snapshot

Return On Equity

-52%

YoY: -18%

Industry median: -47% (n=218)

View history

Return On Assets

-44%

YoY: -21%

Industry median: -44% (n=217)

View history

Current Ratio

4.33x

YoY: -37%

Industry median: 3.67x (n=218)

View history

Quick Ratio

5.14x

YoY: -40%

Industry median: 2.03x (n=83)

View history

Debt-to-equity

0.17x

YoY: +3.7%

Industry median: 0.31x (n=169)

View history

NetIncomeLoss YoY

25%

YoY:

Industry median: -12% (n=211)

View history

Profitability

Metric Latest value YoY change
Return On Equity -52% -18%
Return On Assets -44% -21%

Financial Health

Metric Latest value YoY change
Current Ratio 4.33x -37%
Quick Ratio 5.14x -40%
Debt-to-equity 0.17x +3.7%

Growth

Metric Latest value YoY change
NetIncomeLoss YoY 25%

Share Metrics

Metric Latest value YoY change
Entity Common Stock, Shares Outstanding 75,322,696 +1.7%
Common Stock, Shares, Outstanding 74,986,085 +1.2%
Common Stock, Value, Issued $8,000 +14%
Weighted Average Number of Shares Outstanding, Basic 74,885,348 +1.5%
Weighted Average Number of Shares Outstanding, Diluted 74,885,348 +1.5%

Additional Metrics

Metric Latest value YoY change
Research and Development Expense $196,491,000 +15%
Costs and Expenses $129,623,000 +13%
Operating Income (Loss) $264,736,000 +26%
Nonoperating Income (Expense) $17,431,000 -30%
Earnings Per Share, Basic -3 +34%
Earnings Per Share, Diluted -3 +34%
Cash and Cash Equivalents, at Carrying Value $63,774,000 -46%
Cash, Cash Equivalents, and Short-term Investments $382,700,000 -33%
Accounts Receivable, after Allowance for Credit Loss, Current $40,347,000 +160%
Inventory, Net $12,417,000 +138%
Assets, Current $356,320,000 -24%
Property, Plant and Equipment, Net $19,250,000 +5.4%
Operating Lease, Right-of-Use Asset $6,578,000 +13%
Other Assets, Noncurrent $27,799,000 +88%
Assets $505,356,000 -23%
Accounts Payable, Current $14,929,000 +113%
Employee-related Liabilities, Current $15,596,000 -8.9%
Accrued Liabilities, Current $65,639,000 +17%
Liabilities, Current $82,268,000 +19%
Operating Lease, Liability, Noncurrent $5,693,000 +2%
Liabilities $87,961,000 -1.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax $442,000
Retained Earnings (Accumulated Deficit) $1,236,352,000 -26%
Stockholders' Equity Attributable to Parent $417,395,000 -26%
Liabilities and Equity $505,356,000 -23%
Share-based Payment Arrangement, Noncash Expense $29,948,000 -1.7%
Increase (Decrease) in Accounts Receivable $5,891,000 -161%
Net Cash Provided by (Used in) Operating Activities $68,759,000 +13%
Net Cash Provided by (Used in) Financing Activities $10,609,000 -1822%
Net Cash Provided by (Used in) Investing Activities $73,393,000 +242%
Common Stock, Shares Authorized 150,000,000 0%
Common Stock, Shares, Issued 75,640,711 +1.7%
Common Stock, Par or Stated Value Per Share 0 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $5,975,000 +90%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $64,400,000 -46%
Payments to Acquire Property, Plant, and Equipment $30,000 -95%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $253,378,000 +25%
Operating Lease, Liability, Current $1,700,000 +73%
Preferred Stock, Shares Issued 0
Preferred Stock, Shares Authorized 10,000,000 0%
Additional Paid in Capital $1,678,745,000 +7.6%
Preferred Stock, Shares Outstanding 0
Depreciation, Depletion and Amortization $1,101,000 +51%
Share-based Payment Arrangement, Expense $108,626,000 +6.9%
Preferred Stock, Par or Stated Value Per Share 0 0%

How we score

This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.

Metric Weight V1 threshold
ROIC205% to 20%
ROE158% to 25%
ROA102% to 10%
Operating Margin55% to 25%
Current Ratio121.0x to 2.0x
Quick Ratio80.8x to 1.5x
Debt to Equity100.3x to 2.0x (lower is better)
Revenue YoY10-10% to +20%
Net Income YoY10-10% to +20%

How Calculated (standard_v1)

Metrics are computed with a market-consensus convention designed for cross-portal comparability.

  • TTM Operating Income / TTM Revenues
  • Current Assets / Current Liabilities (latest instant quarter)
  • (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
  • Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
  • TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
  • TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
  • TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
  • TTM Revenues YoY
  • TTM Net Income YoY